Top Injectable Manufacturer in Madagascar – Reliable Pharmaceutical Solutions
- Maulik Sudani
- Jul 21
- 10 min read
Last Updated: July 21, 2026
TL;DR: Madagascar is a market of roughly 33.5 million people in which essentially every sterile injectable is imported. The national regulator's own register of licensed manufacturers lists just three companies — FARMAD, HOMEOPHARMA and PHARMALAGASY — and none of them produces sterile injectables. Demand is severe and rising: malaria cases quadrupled between 2019 and 2024 to an estimated 8.17 million with 20,903 deaths, maternal mortality stands at 445 per 100,000 live births with post-partum haemorrhage the leading direct cause, tuberculosis incidence runs at 224 per 100,000, and the country is currently the global epicentre of the clade Ib mpox outbreak. Market access runs through the Agence du Médicament de Madagascar, which grants a five-year Autorisation de Mise sur le Marché, and through a licensed Malagasy grossiste-répartiteur, since importation and wholesaling are reserved by law to registered pharmacists. Dossiers are accepted in French or English. Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables at a WHO-GMP certified, ISO Class 5 facility in Gujarat, India, exports to over 30 countries, and supports Malagasy partners through AMM registration, SALAMA tender qualification and cyclone-season supply planning.
Key Takeaways
Almost the entire injectable supply is imported. AGMED's official register of licensed manufacturers contains exactly three companies, none with sterile injectable capability, and the agency's own director has confirmed publicly that the majority of medicines consumed in Madagascar are imported. That is the clearest structural argument for a WHO-GMP injectable partner anywhere in the routine.
Two separate gates, not one. AGMED grants the Autorisation de Mise sur le Marché — valid five years, renewable on application three months before expiry, with a statutory maximum four-month decision period — while the Direction de la Pharmacie, des Laboratoires et de la Médecine Traditionnelle is the only body empowered to sign the import authorisation for each shipment. AGMED owns the product licence; DPLMT owns the consignment. Both must be passed, and neither of them is customs.
You cannot import directly, and the local partner choice is consequential. Under the Code de la Santé, importation and wholesale distribution of medicines are reserved to pharmacists, who must be Malagasy nationals, resident in the country and entered on the roll of the Ordre National des Pharmaciens. There are only 27 licensed wholesalers nationally, 21 of them in Analamanga, so partner selection is a small and highly consequential decision.
Stability is Zone IVa, and dossiers may be filed in English. Madagascar's declared long-term storage condition is 30°C/65% RH, communicated by the national authority to WHO; a Zone IVb package at 30°C/75% RH exceeds it comfortably and travels well across the region. AGMED accepts dossiers in French or English, and its manual is explicit that only real-time stability results are taken into account — accelerated data serves only to validate the protocol.
Introduction: Why an Injectable Manufacturer in Madagascar Must Meet Global Standards
Madagascar's public health system reaches its 33.5 million people through roughly 2,945 public facilities — 23 university hospitals, 17 regional referral hospitals, around 101 district hospitals and some 2,800 basic health centres — spread across 114 health districts and 23 regions. The referral tier includes CHU Joseph Ravoahangy Andrianavalona and CHU Joseph Raseta Befelatanana in Antananarivo, CHU Professeur Zafisaona Gabriel in Mahajanga, CHU Analakininina and CHU Morafeno in Toamasina, and CHU Tambohobe and CHU Andrainjato in Fianarantsoa. Alongside this sits a private network of about 300 pharmacies and roughly 1,500 depôts de médicaments. What the country does not have is manufacturing: the regulator's own register lists three licensed pharmaceutical manufacturers, none of which makes sterile injectables. Practically every ampoule and vial administered in Madagascar arrives from abroad.
The clinical need behind that dependence is acute. WHO's most recent figures put Madagascar at an estimated 8,165,311 malaria cases and 20,903 deaths in 2024, roughly four times the 2019 level, with the country identified as one of three driving the majority of the global increase; national guidelines make a strong recommendation for injectable artesunate in severe malaria. Tuberculosis incidence stands at 224 per 100,000, with about 72,000 estimated incident cases against 50,621 notified. Maternal mortality is 445 per 100,000 live births and skilled birth attendance is only 46%, with post-partum haemorrhage the commonest direct cause of maternal death — which places oxytocin and magnesium sulphate near the top of any essential injectable list. Since December 2025 Madagascar has also had the largest clade Ib mpox outbreak in the African region and globally. Non-communicable diseases now account for around 43% of deaths, almost exactly level with communicable and maternal causes. A supplier serving this market is supplying a health system under sustained pressure, and reliability matters more than almost anything else.
What Sets a World-Class Injectable Manufacturer in Madagascar Apart
The first differentiator is verifiable sterility assurance, because Madagascar's own regulator has made quality its stated priority in a market where unauthorised distribution circuits are a live problem. AGMED's director has said publicly that in illicit channels the storage conditions of products are unknown and their quality is not guaranteed — a medicine meant to cure may prove ineffective or dangerous. Against that background, a manufacturer's value is documentary as much as physical. Farbe Firma fills into ISO Class 5 aseptic zones under classified surrounding areas, with validated aseptic processing or terminal sterilisation as the molecule requires, routine media fills, environmental and personnel monitoring, and Water-for-Injection under continuous control. Every batch carries a certificate of analysis stating the pharmacopoeial basis, and batch records are retained so that any consignment can be reconstructed from raw material to release.
The second differentiator is knowing how the two Malagasy gates actually work. The Autorisation de Mise sur le Marché is granted by AGMED after the opinion of the Commission Nationale d'Enregistrement des Médicaments, is valid five years, and requires an administrative dossier that includes a certified GMP certificate for each manufacturing site valid at least six months, the marketing authorisation and Certificate of Free Sale from the country of origin, a Certificate of Pharmaceutical Product in WHO format, the engagement of the pharmacien responsable, a letter appointing the official representative in Madagascar, and draft artwork. AGMED is explicit that a free-sale certificate can in no circumstances substitute for the home-country marketing authorisation. Samples are substantial — 50 vials of injectable solution or powder for a new application, 25 for renewal, each with at least a year of shelf life remaining and accompanied by batch certificates of analysis and 5 g of the active raw material. Separately, before any shipment moves, the importer must submit the product list to AGMED for AMM verification, after which only DPLMT may sign the import authorisation, typically within 48 to 72 hours.
Quality Systems Behind Every Batch We Ship to Madagascar
Every Farbe Firma injectable batch destined for Madagascar is released only after the complete analytical stack is finished and reviewed. Identity, assay and related substances are determined by HPLC and, where the monograph requires it, GC. Sterility and bacterial endotoxin testing by LAL are performed on every batch, alongside container-closure integrity and particulate matter against compendial limits, with Karl Fischer titration for water content where the dosage form demands it. Specifications are set against USP, BP, IP or EP as required and the pharmacopoeial basis is stated explicitly. Because AGMED's registration manual requires stability on three batches signed by the manufacturer and is clear that only real-time results are taken into account, with accelerated data serving merely to demonstrate the soundness of the protocol, our filings are built on completed long-term studies rather than extrapolation.
Labelling discipline matters more in Madagascar than in many markets, because the requirements are prescriptive. The International Nonproprietary Name must appear alongside the commercial name on both primary and secondary packaging, together with strength, pharmaceutical form, batch number, manufacturing date, expiry date, the name and address of the manufacturing laboratory and the name of the AMM holder, with the legal particulars printed indelibly or on non-detachable labels. Secondary packaging carries storage conditions and precautions, List I products take a white label with a wide red border and List II a wide green border, and packaging designed to encourage self-medication is prohibited. Hospital-only presentations are not acceptable on their own, which shapes pack strategy for injectables directly. Farbe Firma prepares French artwork and package leaflets to these specifications, files dossiers in CTD structure re-indexed to AGMED's prescribed order, and holds Zone IVb stability at 30°C/75% RH, which exceeds Madagascar's declared 30°C/65% RH condition and supports the wider Indian Ocean and East African region from the same package.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Injectable Manufacturer in Madagascar for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables at its WHO-GMP certified facility in Gujarat, India, and exports to over 30 countries. The range maps closely onto Madagascar's national essential medicines list, the LNMEIS, whose current edition carries 545 medicines classified against the WHO Model List and includes a dedicated injectables subsection with several hundred references to injectable forms — anaesthetics such as ketamine, propofol and etomidate, local anaesthetics including lidocaine and bupivacaine, emergency agents such as adrenaline and atropine, analgesics from diclofenac to morphine and tramadol, and the broad-spectrum injectable antibiotics that pneumonia, sepsis and obstetric infection demand. Products are coded to six levels of care from CHU down to CSB1, so a supplier that can serve both referral hospitals and basic health centres from one qualified source has a structural advantage.
Our CDMO services scale from a single wholesaler's launch portfolio to central tender volumes. Contract and third-party manufacturing runs under the customer's brand with technology transfer, analytical method transfer, stability commitment and regulatory documentation handled together. For the SALAMA route — the national central medical store, established in 1996, operating from Anosiala with five regional agencies and certified for good storage and distribution practice — we support the continuous international prequalification process, which calls for a technical information sheet, a manufacturer's data sheet and a registration dossier in CTD format. It is worth being precise about sequencing: an AMM is not required in order to bid, but it must be in hand at the time of embarkation, because no unregistered medicine may be presented at a Malagasy port of disembarkation.
Buyers stay with Farbe Firma because we set out the commercial reality rather than a sales version of it. Madagascar is a small, price-sensitive market: health expenditure runs at about US$17.44 per person per year, external donors fund some 38% of it against roughly 29% from government, and wholesaler and distributor margins are administratively capped. Central tenders are typically DDP Antananarivo with VAT included, with a 10% performance guarantee, a four-to-five-month delivery window that can span the November-to-April cyclone season, and a requirement that product arrive with more than three-quarters of its shelf life remaining — terms under which the supplier carries essentially all of the logistics and weather risk. That risk is not theoretical: Cyclone Gezani struck on 10 February 2026 with winds around 180 km/h, severely damaged the port of Toamasina, which handles the large majority of the country's container traffic, and closed it for six days, with customs not fully functional even on reopening. We should also be candid that for Global Fund-financed HIV, tuberculosis and malaria products, WHO prequalification or stringent-authority approval is required, so our realistic entry points are the centrally funded essential-medicines basket, the private wholesale channel and non-donor-financed hospital demand. We plan shipments around the cyclone calendar, build shelf-life headroom into scheduling, and say what we can and cannot serve at the outset.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified injectable manufacturer that can supply Madagascar?
Yes. Farbe Firma Pvt Ltd is a WHO-GMP certified sterile injectable manufacturer and CDMO based in Gujarat, India, producing more than 100 injectable products under ISO Class 5 aseptic conditions and exporting to over 30 countries. For Madagascar we prepare registration dossiers for the Autorisation de Mise sur le Marché, provide certified GMP certificates and a Certificate of Pharmaceutical Product in WHO format, supply French artwork and package leaflets to AGMED's labelling requirements, and hold Zone IVb stability data that exceeds the national condition. Because importation and wholesale are reserved to licensed Malagasy pharmacists, we work through a client's grossiste-répartiteur and its pharmacien responsable.
How is an imported injectable registered in Madagascar, and how long does it take?
The authorisation is the Autorisation de Mise sur le Marché, granted by AGMED after the opinion of the Commission Nationale d'Enregistrement des Médicaments. It is valid for five years and renewable, with renewal to be applied for three months before expiry. The Code de la Santé sets a maximum decision period of four months, counted in practice from receipt of the payment advice, though applicants should plan for longer in reality. Dossiers may be submitted in French or English — a genuine advantage for Indian exporters — and the product must already be registered in another country. Note the annual retention fee, the droit de débit, which market-entry plans frequently overlook.
Does Madagascar have local injectable manufacturing?
No. AGMED's official register of licensed manufacturers lists three companies: FARMAD, established in 1962, HOMEOPHARMA, established in 2003 and focused on herbal and homeopathic products, and PHARMALAGASY, established in 2020 and specified for oral solids and liquids. None of them has identified sterile injectable capability, so essentially all injectable supply is imported. That said, this is not an empty market — several Indian manufacturers are already well established on AGMED's registered-products list, so a new entrant competes on quality documentation, regulatory support and supply reliability rather than on availability alone.
Which stability data does Madagascar require?
Madagascar's declared long-term storage condition, communicated by the national regulatory authority to WHO, is 30°C/65% relative humidity, which corresponds to ICH Climatic Zone IVa rather than Zone IVb. AGMED's registration manual also lists 30°C/75% RH among acceptable long-term conditions, so a Zone IVb package satisfies Madagascar comfortably while also covering Mozambique, Tanzania and much of the wider region. Studies must run on three batches with a minimum of twelve months of real-time data, and the manual is explicit that only real-time results are taken into account — accelerated data serves only to demonstrate that the protocol is sound.
How does public procurement work, and does Farbe Firma need WHO prequalification?
The principal public channel is SALAMA, the national central medical store, which buys in line with the national essential medicines list through a continuous international prequalification tender followed by restricted financial tenders among prequalified manufacturer-product pairs, with consultations and negotiated contracts for emergency or difficult-supply items. SALAMA's prequalification calls for a GMP certificate and a CTD-format registration dossier; WHO prequalification is not demanded for that route. It is required, however, for Global Fund-financed HIV, tuberculosis and malaria medicines, where a supplier must be WHO-prequalified, stringent-authority approved or expert-review recommended. Outside those three disease areas — anaesthetics, analgesics, non-TB antibiotics, cardiovascular products, oxytocin and emergency injectables — a GMP certificate and a Madagascar AMM are what is needed.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog
Comments